In 2022 the UCL CTC established a formal collaboration with The Rose Thompson Foundation. As part of this collaboration Dr Sophia Skyers, a consultant researcher, was commissioned to write a report on the barriers for clinical trials in the Black community. 

Acting on the recommendations of the report, the event Bridging the Gap: Clinical Trials and Black Health was held at Nottingham Trent University on Saturday 19 October. The aims of the event were to engage the Black community in the importance of clinical trials in cancer research. It was an interactive and educational gathering aimed at addressing the significant strides made in cancer treatment through clinical trials and the need for greater participation from Black patients, both adults and children.

Key speakers included experts such as Professor Allan Hackshaw, Dr Okezie Ofor, and Orin Lewis OBE, who shared valuable insights into the role of clinical trials in improving patient outcomes. Topics discussed included how cancer treatments are evaluated through clinical trials, the benefits of these trials for Black patients, and the importance of Black community involvement in research to avoid healthcare disparities. A focus was placed on ensuring that Black patients receive adequate support and information to take part in research without feeling disadvantaged.

Dr Sophia Skyers explored the historical context of medical research, including the story of Henrietta Lacks, highlighting lessons learned from past experiences, and explained the direct impact clinical trials have had on developing cancer therapies. The critical need for diverse participation in clinical trials to advance cancer treatments was emphasised.

Eddie Carr shared his personal journey as a patient involved in clinical research. As a Patient and Public Involvement and Engagement (PPIE) advocate, Eddie highlighted the importance of patient participation in trials, emphasising the benefits and challenges of being part of the research process. 

Workshops provided practical guidance on understanding clinical trial information and identifying trustworthy sources.

The primary goal was to empower attendees to learn about available research opportunities, spread awareness among friends and family, and encourage participation in trials to improve cancer outcomes within the Black community.

Bridging the Gap was the first of many steps, aimed to raise awareness of the value of clinical trials and inspire greater engagement from the Black community to help shape the future of cancer treatment.